Putin Pulls Russia Out of Nuclear Pact That Trump Abandoned
(Bloomberg) -- President Vladimir Putin pulled Russia out of a Cold War-era nuclear pact that's already been abandoned by the U.S., ending more than three decades of agreement on banning short- and medium-range missiles.
Putin signed a law to suspend the 1987 Intermediate-Range Nuclear Forces Treaty, according to a statement Wednesday on the lower house of parliament's website. U.S. President Donald Trump announced in February that he's pulling out of the landmark treaty, which bans deployment of ground-launched missiles with ranges between 500 kilometers (311 miles) and 5,500 kilometers, after he accused Russia of violating the pact, something Moscow denies.
The U.S. and Russia are at loggerheads over nuclear weapons as the clock ticks down on the sole remaining accord between the two powers, the New START treaty that restricts the size of their atomic arsenals and expires in February 2021. Putin said he and Trump agreed during their meeting at the Group of 20 summit in Japan last week to order talks on the issue between Russian Foreign Minister Sergei Lavrov and U.S. Secretary of State Michael Pompeo. Putin cautioned, however, that “I do not know yet if those consultations will lead to the extension of the New START treaty.”
To contact the reporter on this story: Tony Halpin in moscow at thalpin5@bloomberg.net
To contact the editors responsible for this story: Gregory L. White at gwhite64@bloomberg.net, Tony Halpin, Alexei Anishchuk
©2019 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.